Novel once-daily fixed-dose ICS–LABA improves lung function over ICS monotherapy, research findsSubscription
A once-daily fixed-dose combination of inhaled corticosteroids and long-acting β2-adrenoceptor agonist significantly improved lung function over inhaled corticosteroids alone, a phase III study has concluded.
Abrocitinib, an oral Janus kinase 1 selective inhibitor, is effective and well-tolerated in patients with moderate-to-severe atopic dermatitis, a study in JAMA Dermatology has suggested.
A daily prescribing round in a paediatric intensive care unit led to a reduction in prescribing errors and overall time spent on medicines queries and prescribing.
Point-of-care testing for influenza could improve antimicrobial use, feasibility study concludesSubscription
Point-of-care testing for influenza is feasible in primary care and may improve antimicrobial use, a study in the British Journal of General Practice has concluded.
Once-daily ICS-LABA-LAMA superior to ICS-LABA in improving lung function, research suggestsSubscription
A study in The Lancet Respiratory Medicine indicates that ICS-LABA-LAMA once daily is better than ICS-LABA in improving lung function.
Sepsis risk factors could help inform antimicrobial stewardship in primary care, study suggestsSubscription
Risk of sepsis and benefit from antibiotics following a GP consultation for infection are more substantial among those who are older, frail or who have had a urinary tract infection, a study has found.
Pharmacists could screen patients for AF during flu vaccination appointments, study suggestsSubscription
Screening for atrial fibrillation could be carried out during flu vaccination appointments to increase early detection rates, a feasibility study has suggested.
The University of Oxford’s ChAdOx1 nCoV-19 vaccine induces a strong immune response with no serious adverse reactions, preliminary findings of a phase I/II trial published in The Lancet have suggested.